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ABSTRACT 
 
 Alston, Aliza T.  HUMAN PAPILLOMAVIRUS KNOWLEDGE AND AWARENESS 
AMONG NORTH CAROLINA COLLEGE STUDENTS. (Major Advisor: Dr. Doretha 
B. Foushee), North Carolina Agricultural and Technical State University. 
  
 The objective of the present study is to ascertain overall knowledge, attitude and 
awareness of students at select North Carolina Universities about HPV, the HPV vaccine 
Gardasil and the connection between HPV and various cancers.  Five hundred and two 
university students (NCAT, NCCU, ECU and UNCG), 303 females and 199 males, ages 
18 or older (89.6% were between the ages of 18-22) participated in a cross-sectional 
study by completing a survey.  Students at these universities were randomly selected 
based on their enrollment in introductory biology courses for non majors.  Other students 
were chosen randomly by face to face contact in heavily populated areas on the 
campuses, such as the cafeterias, computer labs, libraries, and Student Unions.  The 
survey participants were asked questions about their  gender, ethnicity, age,  
classification, hometown, major, sources from which they receive information on 
sexually transmitted diseases,  sexual activity, sexual partners and date of last physical 
examination.  Participants were then asked a series of knowledge and awareness 
questions about the human papillomavirus. Questions followed to ascertain if participants 
had been diagnosed with HPV, their  awareness of the HPV vaccine Gardasil, and 
whether or not participants had been vaccinated with the Gardasil vaccine.  A knowledge 
scale from 0-18 was designed to look at the overall knowledge of college students.    The 
mean knowledge score was 8.79.  About 65% of the students scored a nine or less.  More 
xiv 
than half of the students answered 50% of the questions incorrectly showing poor 
knowledge of HPV.  Close to 75% of the population scored a 14 or less representing an 
unsatisfactorily level of knowledge.  The population was divided into thirds by either 
wanting to be vaccinated, not being interested in receiving the vaccine, or having been 
vaccinated with the Gardasil Vaccine.  The majority of the students who had not been 
vaccinated with Gardasil reported that it was due to a lack of information on the vaccine 
and the disease.  More emphasis should go towards the development of educational 
materials that educate young adults on the benefits of the HPV vaccine Gardasil.
1 
CHAPTER 1  
Introduction 
 
Human papillomavirus (HPV) is a member of the Papovaviridae family.  More 
than 100 types of HPV, a double stranded DNA tumor virus, exist and are directly related 
to numerous health conditions such as cancer and genital warts.  The viruses of the 
Papovaviridae family are all small and nonenveloped, meaning that they have no lipid 
bilayer surrounding their capsid, the protein coat surrounding the genome.  “Their capsid 
is an icosahedron, or a polygon with 20 faces and is 55-nm in diameter” (Baldwin, 
Edwards, Grace, Hayakawa, Huh, Nguyen, Münger, & Owens, 2004; Greenblatt, 2005; 
Sinal & Woods, 2005).  The most common types of Human Papillomavirus are types 6, 
11, 16, and 18.   The development of genital warts is primarily induced by HPV types 6 
and 11, while HPV types 16 and 18 are associated with the development of 
approximately 70% of all cervical cancers (Bosch, Castellsague, Diaz, de Sanjose, 
Hammouda,  Shaw, Meijer, & Munoz, 2004; Lowy, Kirnbauer & Schiller, 1994).  The 
human papillomavirus is as regular as the common cold.  Currently, it is estimated that 20 
million Americans are infected with HPV and that another 6 million will become infected 
each year (Centers of Disease Control and Prevention [CDC], 2010).  The Center for 
Disease Control and Prevention (CDC) has estimated that 50% of sexually active 
individuals will acquire a general human papillomavirus infection during their lifetime.  
Human papillomavirus statistics indicate that the chance of a sexually active individual 
becoming infected with HPV during his or her lifetime is 75% or higher.  Human 
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papillomavirus spreads by intimate skin to skin contact, and by sexual activity, including 
oral sex.  Although there are treatments for the clinical manifestations of HPV infection, 
there is no cure for the infection (Akers, Andraos-Selim, Bondzi,  Edwards, Gollim, 
Hagan,  Heron, Jones, E.A., Jones, J., Moss, Smith, Taioli, Thurman, & Ragin, 2009). 
Almost twenty years ago, researchers discovered a link between HPV and cervical 
cancer (CDC, 2010).  Cervical cancer is the second most common cancer among women 
world-wide and is the leading cause of female cancer deaths in developing countries 
(Parkin, 2005).  Women usually receive the Papanicolaou (Pap) Smear Test yearly in 
developed countries.  If the test is abnormal, additional cytological test are implemented 
to determine if the individual has cervical cancer (Beusterien, Dixon., Fleurence,  & 
Milanova, 2007).  “Potential cell findings can range from atypical squamous cells of 
undetermined significance; atypical squamous cells cannot exclude high-grade squamous 
intraepithelial lesion; atypical glandular cells; high-grade squamous intraepithelial lesion; 
and low-grade squamous intraepithelial lesion” (Cox, Massad, Twiggs, Wilkinson, & 
Wright, 2002).   Research has indicated that 99% of all cervical cancers, are caused by 
high risk HPV virus types 16 and 18 (CDC, 2010).  In most cases the body is able to clear 
the HPV infection; however, if the infection is not cleared, an accumulation of abnormal 
cells could develop in the cervix.  The abnormal cells caused by HPV are directly linked 
to cervical cancer. 
Currently, thirty types of the HPV are linked to anal or penile cancers in men.  
Less than one percent of the males in the United States were estimated to have been 
diagnosed with penile and anal cancer in 2007 (CDC, 2010).  Men have less prevalence 
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and incidence of cancers induced by HPV than women.  However, the risk of anal cancer 
is seventeen times more likely for bisexual or homosexual men in comparison to men 
who are heterosexual (CDC, 2010).   
 There is no cure for HPV, simply treatment for the irregularities caused by HPV. 
Maintaining abstinence from sexual activity is the only certain way to prevent HPV.  The 
usage of condoms reduces the risks of contracting HPV; however, areas that are not 
covered by the condom are open to exposure to HPV.  Individuals can lower their risk of 
HPV by limiting sexual partners, staying in monogamous relationships, and selecting a 
partner with limited previous partners.  Before individuals become sexually active, or 
after becoming sexually active and before being exposed to the HPV, it is imperative that 
individuals receive the HPV vaccine. This will decrease the spread of HPV, and the 
number of cases of genital warts and cancers linked to HPV. 
Recently, the United States (US) Food and Drug Administration (FDA) approved 
Gardisil, the first vaccine which is effective against human papillomavirus types 6, 11, 
16, and 18, for young men and women between the ages of 9 to 26.  The vaccine, 
manufactured by Merck Pharmaceutical Company, was originally approved for women in 
June 2006 and for men on October 9, 2009 (CDC, 2010).  Gardasil is currently being 
offered for approximately $120 per single dose.  Gardasil requires three doses during the 
duration of 6 months, a total cost of $360.  Additionally, some physicians charge office 
visit and injection fees at the time of vaccination.  Though another vaccine, 
GlaxoSmithKline’s Cervarix, was approved by the FDA in 2009 to protect against strains 
16 and 18, the focus of this research will be specifically on Gardasil.  Gardasil is the most 
4 
popular vaccine in the United States, as it has been on the market the longest and its 
familiarity to society is greater. 
  We hypothesize that college students will be aware of HPV overall, but that 
there will be misconceptions about the virus and only a few students will have been 
vaccinated.  We further hypothesize that qualitative factors will correlate directly to the 
amount of knowledge and awareness about HPV and the attitude of students towards the 
Gardasil vaccine. 
Students at four universities in North Carolina were administered a twenty-seven 
question survey.  Data was analyzed using SPSS Software. 
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CHAPTER 2 
Literature Review 
 
2.1 Papillomavirus Discovered  
The first papillomavirus, the cottontail rabbit papillomavirus (CRPV), was 
discovered in the 1930s by Richard Edwin Shope.  Cottontail Rabbits in northwestern 
Iowa and southern Kansas were described by hunters as having, “numerous horn-like 
protuberances on the skin of various parts of the body” (Shope, 1933).  The 
protuberances are now referred to as “warts.”  Peyton Rous and Joseph Beard exposed 
“the cancerous potential of the wart virus in 1935, by showing it failed to replicate and 
produce warts in the domestic rabbit, but instead induced the formation of skin 
carcinomas after an extended period of time” (Beard & Rous, 1935).  The first known 
tumor virus, CPRV became an important model for showing the progression of 
carcinomas.  Not until 30 years later, when HPV infection was connected to human 
cancer, would the significance of work done by Richard Shope, Peyton Rous and Joseph 
Beard be recognized for its upmost importance ( Butel & Javier, 2008). 
 
2.2 Classification and Structure of HPV 
The human papillomavirus is classified as a member of the Papovaviridae family.  
This is a large family of double stranded DNA tumor viruses (Baldwin et al., 2004; 
Doorn, Kleter, Molijin, & Quint, 2005; Greenblatt, 2005; Sinal & Woods, 2005).  The 
HPV genome contains 8 kb of double stranded circular DNA.  Currently, over a hundred 
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different strains of this virus have been identified that directly infect human beings.  The 
viruses of the Papovaviridae family are all small and nonenveloped, meaning that they 
have no lipid bilayer surrounding their capsid, the protein coat surrounding the genome.  
The shape of the capsid is an icosahedron with 20 faces, and is 55-nm in diameter 
(Baldwin et al., 2004; Greenblatt, 2005; Sinal & Woods, 2005).  The genome has eight 
open reading frames coding for early proteins (E1, E2, E4, E5, E6, and E7) and late 
capsid proteins (L1 and L2).  Early proteins E1 and E2 participate in viral replication. 
The E4 protein contributes to controlling the host cell cycle, and E5 assists in cell 
transformation and viral replication.  Oncoproteins E6 and E7 take part in malignant 
transformation of cervical cells; they also form specific complexes with tumor suppressor 
gene products tumor protein 53 (p53) and retinoblastoma (pRb).     
 The human papillomavirus is categorized into high risk types (16, 18, 31, 33, 35, 
39, 45, 51, 52, 56, 58, 59, 68, 73, and 82), probable high risk types (26, 53 and 66) and 
low risk types (6, 11, 40, 42, 43, 44, 54, 61, 70, 72, 81, and CP6108) (Bosch et al., 
2004Gnanamony, 2007).  High risk types of HPV 16 and 18 cause growth on the cervix 
that are usually level and out of sight, when contrasted to the external warts caused by 
low-risk types HPV 6 and 11 (Human Papillomaviruses and Cancer: Questions and 
Answers, 2010).  High risk types 16 and 18 cause cervical cancer, severe cervical 
dysplasia, anogenital cancers, in addition to head and neck cancers (Rapose, 2009).  It is 
important to mention, that a great majority of high risk HPV infections go away on their 
own and do not cause cancer (Castle, Rodriguez, Schiffman, & Wacholder, 2007).   
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2.3 Life Cycle of HPV 
The introduction of HPV into the human body is a controversial issue.  Scientists 
suggest the accessibility of HPV is permitted through a break in the stratified epithelium 
cell layer (Doorbar, 2005).  However, there is still a debate over the specific cell surface 
receptor that allows the initial attachment of the virus.  Scientists also suggest a 
dependence on the presence of the linear polysaccharide, heparin sulphate (Cook,  
Janesn, Joyce, Keller, Lehman, Przysiecki, Sands, & Tung, 1999).  Heparin sulphate 
attaches to different protein ligands to normalize numerous biological activities, 
including tumor metastasis.  
The human papillomavirus has been shown to penetrate through the host cell by 
different pathways, namely clathrin-mediated endocytosis, caveolar endocytosis, and 
clathrin- and caveolae-independent endocytosis.  “In the course of the clathrin-mediated 
endocytosis pathway, the binding of a ligand to a specific receptor clusters the ligand-
receptor complexes in the coated pits on the plasma membrane.  This pit invaginated and 
pinched off from the plasma membrane forms intracellular clathrin-coated vesicles in 
progress to early endosomes before being fused to form late endosomes or lysosome” 
(Letian & Tianyu, 2010).  The caveolar endocytosis pathway is used a lot less than the 
clathrin- mediated endocytosis pathway.  Research shows that HPV-31 uses caveolar 
endocytosis by passing through the caveosomes, avoiding the endosomes, and moving to 
the endoplasmic reticulum or the golgi apparatus (Campos, Ozbun, & Smith, 2007; 
Holthusen, Laniosz, & Meneses, 2008).  Clathrin- and caveolae-independent endocytosis 
are the pathways used by HPV-16.  Evidence is provided by “the transmembrane domain-
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containing proteins tetraspanins that are able to interact laterally with each other and with 
other transmembrane proteins to form tetraspanin-enriched microdomains (TEMs) , 
within which tetraspanins can control and modulate complicated activities including 
adhesion, migration, and synapse formation, as well as endocytosis and exocytoses” 
(Hemler, 2003; Levy & Shoham, 2005).  The life cycle of human papillomavirus is still 
not completely understood, considering the virus has over 100 different known strains 
which take different pathways.  
 
2.4 HPV and Cancer 
Almost twenty years ago, researchers determined an association between HPV 
and cervical cancer (CDC, 2010).  Cervical cancer is the second most common cancer 
among women world-wide and is the leading cause of female cancer deaths in developing 
countries (Parkin, 2005).  Sexually active women usually receive the Papanicolaou (Pap) 
Smear Test as a part of their yearly physical examination in developed countries.  If the 
test is abnormal, different cytological test are implemented to determine if cancerous 
cells are present on the cervix (Beusterien et al., 2007).  “Potential cell findings can range 
from atypical squamous cells of undetermined significance (atypical squamous cells 
cannot exclude high-grade squamous intraepithelial lesion); atypical glandular cells; 
high-grade squamous intraepithelial lesion; and low-grade squamous intraepithelial 
lesion” (Cox et al., 2002).   Research has indicated that 99% of all cervical cancers are 
caused by high risk HPV types 16 and 18 (CDC, 2010).  However, other high risk types 
of HPV 18, 31, 33, 45 are also linked to cervical cancer.  In most cases the body is able to 
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clear the infection of the system by HPV; however, if the infection is not cleared, an 
accumulation of abnormal cells could still be present in the cervix.  The abnormal cells 
caused by HPV are directly linked to cervical cancers. 
Currently, thirty types of the HPV are linked to anal and penile cancers in men. 
The high risk cancers associated with anal cancers in men are HPV types 16, 18, 31, 33 
and 45.  Less than one percent of the males in the United States were estimated to have 
been diagnosed with penile or anal cancers in 2007 (CDC, 2010).  Men have less 
prevalence and incidence of cancers induced by HPV than women.  Research also 
indicates that men who have been circumcised have a lesser chance of developing HPV.  
However, the risk of anal cancer is seventeen times more likely for bisexual or 
homosexual men in comparison to men who are heterosexual (CDC, 2010).   
In 2007, a case-control study showed that individuals with high numbers of oral 
sex partners were three times as likely to develop Oropharyngeal cancer caused by HPV 
16 (Gypsyamber, 2007).  Also, the study indicated a higher risk of throat cancer by 
eightfold for individuals with more than six oral sex partners.  A review of the literature 
also showed that HPV 16 and 18 were also linked to head and neck cancers.  Head and 
neck cancers are extremely rare, affecting below one percent of Americans a year.  
However, the incidence of head and neck cancers is increasing. 
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2.5 Gardasil and Cervarix 
Currently on the market are two vaccines, Gardasil and Cervarix, that provide 
immunity against HPV types 16 and 18.  Gardasil is a quadrivalent vaccine, because it 
also provides immunity for HPV types 6 and 11 which are linked to genital warts and 
respiratory papillomatosis.  Gardasil has been on the market the longest and provides 
protection for young males and females between the ages of nine and twenty-six.  
Cervarix is a bivalent vaccine that provides protection for women between the ages of ten 
and twenty-five.  Both vaccines are made using recombinant DNA technology.  Cervarix 
contains inactive purified L1 proteins of HPV types 16 and 18; Gardasil contains purified 
L1 proteins of HPV types 6, 11, 16 and 18.  A cell that has been engineered to contain the 
L1 gene allows the vaccines to produce the L1 protein.  The proteins assemble to form 
virus like particles.  Both vaccines have an adjuvant system containing an aluminum 
compound.  Adjuvants are used to help stimulate a better immune response to 
vaccination.   
Many clinical trials have been conduct on these two vaccines.  A head to head 
clinical trial study sponsored by the Cervarix manufacturer, GlaxoSmithKline, indicates 
that Cervarix also generates cross protection against high risk HPV types 31, 33, and 45.  
It was also reported that Cervarix induces larger serologic responses against HPV types 
16 and 18 in comparison to Gardasil.  Overall, the two vaccines efficiently protect 
women against cervical cancer.  Close to thirty million doses of Gardasil were 
administered in the United States in 2010.  Gardasil is the popular vaccine in the United 
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States, as it has been on the market the longest and its familiarity to women and doctors is 
greater.  This is the primary reason that our research will focus solely on Gardasil.  
 
 
2.6 Immune Response to the Gardasil Vaccine and HPV Infections 
 The Gardasil vaccine is injected into the upper arm or upper thigh of the body.  A 
total of three injections of the Gardasil vaccine must be administered within a six month 
period.  The virus-like proteins (VLPs) in Gardasil are very similar to the HPV virus. 
“Virus-like particles (VLPs) are multiprotein structures that mimic the organization and 
conformation of authentic native viruses but lack the viral genome, potentially yielding 
safer and cheaper vaccines” (Alves, Carrondo,  Castilho,  & Roldão, 2010).  The proteins 
have the ability to activate the innate (birth) and adaptive (acquired) immune response 
(Mariani, & Venuti, 2010).  When Gardasil is injected into the body, the immune system 
realizes the VLPs found in Gardasil are foreign. Then the immune system starts to 
develop antibodies against the VLPs to provide immunity.  If the body is exposed to HPV 
after vaccination, the body will be prepared to fight off the infection.  Currently, research 
is being conducted to see how long the vaccine provides immunity and determine if a 
booster shot should be administered to induce the development of a more robust immune 
memory. 
 Genital HPV infection is primarily a sexually transmitted infection but penetrative 
vaginal or anal sexual intercourse is not a prerequisite for infection.  Virus is also 
transmitted by skin to skin contact via intimate contacts of the genitalia or other mucosal 
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surfaces (Kjaer, Moscicki, Schiffman, & Villa, 2006).  Almost immediately after 
becoming sexually active one is at their peak period for acquiring an HPV infection and 
their chances increase with the number of sexual partners (Binns, Coleman, Deacon, 
Desai, Elanko, Evans, Gilham, Haywod, Peto, Taylor, & Yule, 2004; Koutsky, 1997).  
According to M. Stanley, many infected individuals mount an effective immune 
response, becoming DNA negative with subsequent sustained clinical remission from 
disease.  Effective immunity requires a cell mediated response to proteins E2 and E6, 
which is essential for lesion regression, accompanied by sero-conversion and antibody to 
the major capsid protein L1 (Coleman, Crawford, Kwappenberg, Stanley, van der Burg, 
van den Hende, & Woo,2010; Stanley, 2010).  The immune response to HPV infection is 
still not completely understood in its entirety.  
 
2.7 Safety of the Gardasil Vaccine 
The US Vaccine Adverse Event Reporting System (VAERS) reported a total of 
12,424 adverse events after immunization with Gardasil in the United States between 
June 2006 and December 2008 (Chustecka, 2009).  At this time, an estimated 23 million 
doses of Gardasil has been dispersed throughout the United States (Chustecka, 2009).  
Seven hundred and seventy-two reports (6.2% of the total) were described as serious, 
including 32 reports of death (Chustecka, 2009).  The most frequently reported adverse 
reactions were local injection site reactions, nausea, dizziness, and fainting (Agorastos, 
Brotherton,  Chatzigeorgiou, & Garland, 2009).  In 2008 a meeting was held by the 
Advisory Committee on Immunization Practices (ACIP) , an independent panel of health 
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expert (CDC, 2008), this committee found no epidemiological evidence of a link between 
Gardasil and any serious adverse effects (Agorastos et al., 2009).  The review of the 
literature shows the risks associated with the vaccine are general when compared to that 
of any vaccine currently on the market. 
 
2.8 Knowledge and Awareness of HPV Studies 
 A survey was distributed to college students from Florida State University (FSU) 
and Florida Agricultural & Mechanical State University in 2007.  The purpose of the 
study was to assess the awareness, knowledge, and beliefs about human papillomavirus in 
a racially diverse sample of young adults.  A total of 124 students participated in the 20 
question survey.  The study participants were of black or African-American descent by 
57%, 32% white, 5% biracial, 3% Asian and 3% Latino/Latina (Gerend & Magloire, 
2008).  The results provided evidence that 75% of the students had heard of the human 
papillomavirus, though there were misconceptions about the virus, general knowledge of 
HPV was high (Gerend & Magloire, 2008).  In their study, women had more knowledge 
and awareness of the HPV than men.  Participants with a high number of sexual partners 
and those who were sexually active had a higher perception of risks associated with the 
virus.  The study participants who were less educated about the virus were younger in 
age.  The minority population, African Americans and sexually active participants 
reported immense interest in HPV education.  This is one of the first published 
documents discussing the knowledge and awareness of a racially diverse group of young 
college students in the United States. 
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The University of Pittsburgh surveyed 202 adults in the general population of 
Pittsburgh, Pennsylvania, and Hampton, Virginia.  The survey was used to evaluate 
knowledge about HPV and the HPV vaccine, and the perception of the vaccines 
efficiency and safety (Akers, et al., 2009).  The methods used to distribute the surveys 
were face to face or by mail. In Hampton, Virginia the participants were recruited 
through flyers posted at churches, community centers, outpatient clinics, health fairs, 
school events, libraries, the local newspapers, and the University of Pittsburgh Medical 
Center newsletters (Akers, et al., 2009).  The Hampton population consisted of 
participants from Hampton and surrounding communities, such as the local plasma 
donation center, churches, the local police station, and also students and staff members 
from the Hampton University campus (Akers, et al., 2009).  The ethnicity of survey 
participants evaluated were 55% white, 45% black and 1% other for the two populations.  
It was determined that the overall population 93.6%; Pittsburgh: 95%; Hampton: 90% 
had heard of the human papillomavirus (Akers, et al., 2009).    
 The literature is very limited regarding the overall knowledge and awareness of 
the HPV vaccine in young adults in the United States.  Many Americans do have some 
knowledge and awareness of HPV through internet sources, doctor visits, television 
commercials and billboards.  Research shows that around the world in Signapore, 
Malyasia, Australia, and the Netherlands HPV vaccination programs are currently 
ongoing.  Surveys were conducted in these areas to test the current knowledge and 
awareness of the human papillomavirus, to develop measurements to further educate their 
citizens.  
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2.9 Young Men’s and Women’s Attitude towards HPV 
Prior to the Gardasil vaccine being made available to males, a private university 
in the Northeast assessed the attitude towards the human papillomavirus in 2009.  Six 
focus groups composed of a total 45 men aged 18-22, participated in discussions that 
were audio taped and transcribed verbatim, and initial coding categories were developed 
(Allen, Fantasia, Fontenot, Flaherty, & Santana, 2009).  It was found that the men had a 
lot of misconceptions about the human papillomavirus.  The majority acknowledged that 
infection could be serious for women, and referred to HPV as a woman’s disease (Allen, 
et al., 2009).  Unfortunately, science reveals that this is not the case, because HPV is an 
equal opportunity offender.  They asked their participants if they would receive the 
vaccine if it became available to them.  In turn apprehension was voiced about the cost, 
accessibility, safety and side effects (Allen, et al., 2009).  Many males were hesitant to 
receive the vaccination for themselves, men considered the vaccination of women would 
be very beneficial (Allen, et al., 2009).   
A study was conducted to see why only ten percent of young women in the 
United States had been vaccinated against the human papillomavirus.  One hundred and 
eighty five non-vaccinated women aged 19-26 participated in the 2007 study.  Most 
respondents agreed that cervical cancer is a devastating disease (93.5%) and that genital 
warts are an embarrassing condition (90.0%) (Good, Vichnin, Weiss, & Zimet, 2010).  
The common perceived barriers to vaccinations was that the women were married or felt 
as if they were in a true monogamous relationship.  About a third of the respondents 
thought the vaccine was too new or that they did not have enough information about it 
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(Good, et al., 2010).  There was also the concern about whether insurance companies 
would cover the vaccination. 
The attitude of both men and women seem to stem from a limited access to 
information about the human papillomavirus infections, vaccine safety, and insurance 
coverage. 
 
2.10 Urban and Rural Defined 
  After reviewing the literature, it was determined that many different definitions 
are used to define urban and rural.  The Census Bureau divides "urban" into two different 
categories either “urban cluster” or “urbanized area.  Urban clusters have a population of 
at least 2,500 but is less than 50,000.  Urbanized areas have an urban nucleus of 50,000 
or more people (U.S. Census Bureau, 2000).  The Office of Management and Budget 
(OMB), a federal agency that helps to advise the president on federal spending, has a 
definition of “urban” based on Census data.  The federal government has created many 
different methods for defining rural America, which are used to delegate how 
government funds are allocated to the public (Judge & Wingrove, 2004).  There is no 
universally accepted definition of “rural” across Federal Agencies (Judge & Wingrove, 
2004).  The Census defined "rural" as areas comprising open country and settlements 
with fewer than 2,500 residents ( U.S. Census Bureau, 2000).   
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2.11 North Carolina Demographics 
In 2000, the United States Census Bureau reported that North Carolina was one of 
the most rapidly growing states from the previous decade.  According to the North 
Carolina State Demographer, a majority of the population lived in 16 of the state’s 100 
counties (Mecklenburg, Wake, Guilford, Forsyth, Cumberland, Durham, Buncombe, 
Gaston, New Hanover, Union, Onslow, Cabarrus, Johnston, Davidson, Pitt, and 
Catawba).  Despite the growing populations, over a million North Carolinians are left 
uninsured.  Sadly, the highest groups of uninsured citizens are young adults ages 9-26.  
To decrease this devastating statistic, the North Carolina University System mandated 
that all college students who registered for classes in the fall of 2010 have health 
insurance.  The effects of the mandate should enhance vaccination rates and increase 
awareness of the human papillomavirus. 
 
2.12 Knowledge Gaps to be Addressed 
The survey of the general populations of Pittsburgh, Pennsylvania, USA and 
Hampton, Virginia, USA failed to explore proper assessment of one’s attitude towards 
the HPV vaccine.  The study focused more on perceptions towards the efficacy and safety 
of the Gardasil vaccine.  The survey of the two historically black universities in Florida 
should have tested the majority populations (whites) as well for statistical purposes.  My 
research is intended to fill gaps of prior research studies, by looking at a greater number 
of diverse populations by surveying racially diverse students at select North Carolina 
Universities.  The populations selected to be surveyed are East Carolina University, 
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North Carolina Agricultural & Technical State University, North Carolina Central 
University, and the University North Carolina at Greensboro.  North Carolina Central 
University and North Carolina Agricultural & Technical State University are historically 
black public universities.  East Carolina University and the University North Carolina at 
Greensboro are two public universities that are historically white.  The attitude and 
knowledge of HPV will be addressed in men and women.  Also we will look at the 
hometown communities of survey participants, to determine if urban or rural areas have 
more individuals who have received the Gardasil vaccination.  The information gathered 
from this research study will provide insight that will be used in the development of 
educational materials designed to increase the knowledge and awareness of HPV and 
HPV vaccinations, among college students.  
 
2.13 Significance of this Research 
Surveying diverse populations could generate data that will help with research in 
the fields of marketing, preventive medicine, and clinical trials.  Comparisons made from 
the quantitative and qualitative analysis will contribute toward improved knowledge of 
the relative importance of educating people on HPV and HPV vaccinations.  Hence, this 
knowledge will help decrease the number of infections and diseases caused by this virus.  
 
 
 
 
19 
CHAPTER 3 
Materials and Methods 
 
3.1 Survey Development and Design 
The survey study was designed to ascertain  knowledge and awareness of students 
at select North Carolina Universities about HPV, the HPV vaccine Gardasil, and the 
connection between HPV and various cancers .  This study also sought to determine if 
qualitative factors such as gender and ethnicity will influence the knowledge, awareness, 
and attitude of students about HPV and the Gardasil vaccine.  The survey participants 
were asked questions that described their  gender, ethnicity, age,  classification , 
hometown, major, sources from which they receive information on sexually transmitted 
diseases,  sexual activity, sexual partners and date of last physical examination.  For the 
purpose of my study, “urban” is defined as those populations with more than 50,000 
inhabitants.  “Rural” is defined as those populations with less than 50,000 people.  
Participants were then asked a series of knowledge and awareness questions about the 
human papillomavirus.  Followed by  questions to ascertain if participants had been 
diagnosed with HPV, their  awareness of the HPV vaccine Gardasil, and whether or not 
participants had been vaccinated with the Gardasil vaccine.  The survey was pretested on 
a small group of students and faculty members at North Carolina Agricultural & 
Techinical State University and modified as necessary.  We determined that the survey 
instrument was validated to achieve the objectives of this study. 
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3.2 Study Participants 
 College students attending East Carolina University (ECU), North Carolina 
Agricultural & Technical State University (NCAT), North Carolina Central University 
(NCCU), and the University of North Carolina at Greensboro (UNCG) were asked to 
participate in this study.  These schools were selected because they are all public 
universities in the State of North Carolina.  Two of the institutions, NCA&TSU and 
NCCU, are historically black universities and two of the universities, ECU and UNCG, 
are historically white.  This voluntary survey was distributed to students at these 
universities randomly selected based on their enrollment in introductory biology courses 
required for non majors.  This is a course required for all students regardless of their 
major.  Other students were chosen randomly by face to face contact in heavily populated 
areas on the campuses, such as the cafeterias, computer labs, libraries, and Student 
Unions.  
 
3.3 Research Compliance 
 The survey entitled, “Human Papillomavirus (HPV) Knowledge and Awareness 
among North Carolina College Students” and an informed consent form  was reviewed 
by the Institutional Review Board (IRB) at North Carolina Agricultural & Technical State 
University, and was determined to be exempt from further review according to 45 CFR 
46.101(b) (Appendix).  The seal of approval was granted on October 5, 2010 by NCAT.  
The North Carolina Agricultural & Technical State University seal of approval was then 
recognized and accepted at East Carolina University, North Carolina Central University, 
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and the University of North Carolina at Greensboro in the Fall semester of 2010 
(Appendix).  
 
3.4 Survey Administration Protocols 
  Participants were asked to read the Informed Consent Letter.  They were also 
made aware of the potential risks and benefits of participation in this survey.  Participants 
who voluntarily provided Informed Consent were asked to respond to survey questions.  
Students required approximately 10 minutes to complete the survey responses.  To 
protect the privacy of study participants, surveys were collected by having students put 
them in an envelope.  
 
3.5 Statistical Analysis 
 The statistical computer software SPSS (V 18.0) was used to analyze the collected 
survey data.  Initially, descriptive analysis of the quantitative variables was conducted.  
The relationship between students’ knowledge of HPV and the independent variables 
(age, ethnicity, gender, major, and school) was determined using the chi-square test.  The 
significance level for this study was set at 5% (alpha = .05) 
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CHAPTER 4  
Results and Discussions 
 
4.1 Characteristics of the Study Population 
 A total of 502 surveys were collected from students attending East Carolina 
University, North Carolina Agricultural & Technical State University, North Carolina 
Central University, and University of North Carolina at Greensboro (Figure 1.1).  The 
largest number of survey participants attended the University of North Carolina at 
Greensboro (30.5%).  North Carolina Agricultural & Technical State University 
represented 27.3% and East Carolina followed closely at 24.3%.  The lowest number of 
respondents attended North Carolina Central University (17.9%).  Each university 
contributed between 17.9% to 30.5% towards the total population.  In this study 60.4% of 
the participants were female and 39.6% were males.  This gender distribution was also 
reflected within each school.   
             Past research studies in Florida compared students from a historically white 
university (Florida State University) and a historically black university (Florida 
Agricultural & Mechanical State University) as reported by Gerend and Magloire in 
2008.  The current study consisted of two historically white universities (ECU and 
UNCG) and two historically black universities (NCAT and NCCU) in the state of North 
Carolina. The current study surveyed four times as many students compared to the 
Florida study which only surveyed 124 students.  
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Figure 1.1 Distribution of Participants at the Four Selected Universities. 
The percentage of survey respondents that attended East Carolina            
University was 24.30%, North Carolina Agricultural & Technical State 
University 27.29%, North Carolina Central University 17.93% and 
University of North Carolina at Greensboro 30.48%. 
 
           4.1.1 Ethnicity. The largest ethnic groups were black and white as reflected in 
Table 1.1.  Less than 1% of the respondents identified themselves as Other or Native 
American.  Asian American, Southeast Asian /Asian and Hispanic/Latino were 2.2% of 
the population.   Individuals who classified themselves as multi- racial represented 6.6%, 
54.4 % were of African American/Black/African Descent, and 33.5% were 
Caucasian/White.  All other ethnic groups together made up only about 10% and were 
not included in further analyses.  Therefore, we focused on African 
American/Black/African Descent and Caucasian/White in this study. 
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Table 1.1 Ethnic Distribution of the Participants 
Ethnicity Percent % 
Asian American/ Southeast Asian/ Asian 2.2 
African American/ Black/African Descent 54.4 
Caucasian/ White 33.5 
Hispanic/ Latino 2.2 
Multi-Racial 6.6 
Native American 0.6 
Other 0.6 
Total 100 
 
4.1.2 Age Group. The vast majority of respondents (89.6%) were between the 
ages of 18-22 (Figure 2.1).  Less than 7% of the respondents were between the ages of 
23-26 and only 3.4 % were older than 26.  We expected that the majority of our 
population would be between the ages of 18-22, because we were sampling colleges with 
majority undergraduate students.   
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Figure 2.1 Age Group Distribution of Survey Participants. 
Respondents according to age were less than 18, 18-22, 23-            
26, or older than 26.  
 
4.1.3 Classification. Nearly 60% of all survey participants were freshmen or 
sophomores.  Juniors represented nearly 20% of the population and seniors 16%.  
Graduate students were least represented in this sample (3.8%).  We had student 
representation from all classifications (Figure 3.1).   
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Figure 3.1 Distribution of Participants’ Classification 
Majority of survey respondents were sophomores or       
freshmen 60.6%, juniors represented 19.5%, seniors 
16.1% and graduate students 3.8%.  
 
4.1.4 Major. Students of different majors participated in this survey.  The most 
common majors among the public universities were Economics/Business 15.3%, Nursing 
8.96%, Civics/Social sciences 8.37% and Education 8.17% of the population.  Other 
majors represented in this study were Math/ Physics, Biology/Chemistry, Agriculture, 
Animal Science, Athletic Training and Pre-Law.  Although these majors were 
represented in this study, they were not as well represented as the above mentioned 
majors.  A larger representation of biology and chemistry majors would have allowed us 
to determine if there is a significant difference in the knowledge and attitudes of students 
in majors typically considered to be more closely aligned with biomedical sciences. 
Overall, a very diverse sample of majors was obtained from the study population.   
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4.2 Sources of Receiving Information on Sexually Transmitted Diseases  
The most common ways college students receive information on STDs and STIs 
is through the Physician or from the Student Health Center (74.5%); followed by the 
internet (71.5%) (Table 2.1).  Over 60% of the participants received information on STDs 
and STIs by watching television or by word of mouth from parents, guardians or friends.  
Less than 50% of the participants received information by reading magazines, books and 
newspapers. 
 
Table 2.1 Participants were asked for their Sources of Receiving Information                                                                                                                 
                 Related to Sexual Health and STDS   
Sources of Information Percentage of those Receiving 
Information 
Physician or Student Health Center                              74.5% 
Television                              63.1% 
Internet                              71.5% 
Health Classes                              68.9% 
Magazines, Books and Newspapers                              44.0% 
Word of Mouth (Parents/Guardian, Friends, 
Teacher) 
                             61.6% 
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4.3 Physical or Gynecological Examinations 
Fifty-four percent of the survey respondents had received a physical or 
gynecological exam six months ago and 22.7% had received an examination within the 
last year.  Only 15% reported that they had received a physical examination more than a 
year ago, and less than 10% of the population had never received a physical or 
gynecological exam.  
Overall, close to 90% of blacks had been examined by their physician within the 
last year compared to 66.5% of whites.  Almost two times as many blacks reported that 
they had been examined by their physician six months ago in comparison to whites.   
  There are dramatic differences between the regularity of physician visits of 
whites and blacks (Table 3.1).  This data differs from a research study conducted by the 
CDC which interviewed households from 1997-2009. Their research study showed no 
significant difference between blacks (46.5%) and whites (46.8%) who reported visiting 
their physician one to three times in 2009.  The difference in the current study could be 
because blacks have a higher risk for contracting such diseases like HIV.  The Center for 
Disease Control and Prevention reported that 52% of African Americans were diagnosed 
with HIV in 2008; whereas only 29% of whites were diagnosed with HIV. 
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Table 3.1 Physical Examinations amongst Blacks and Whites 
 African American/Black Caucasian/White 
Never 5.5% 11.9% 
More than a year ago 8.4% 21.4% 
A year ago 19.4% 29.2% 
Six months ago 66.7% 37.5% 
Total 100% 100% 
 
4.4 Sexually Activity and Sexual Partners 
Overall, 79.1% of the survey participants reported being sexually active, and 
20.9% reported that they were not sexually active.  Females (77.6%) and males (81.4%) 
reported being sexually active.  Almost an equal proportion (37%) had 0-1 or 2-3 sexual 
partners in the last three years (Figure 4.1).  Whereas 10.6% of the population had 4-5 
sexual partners, and 16.3% had more than 5 sexual partners.  Further analysis shows a 
difference in sexual partners according to ethnicity and between white and black males. 
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Figure 4.1 Distribution of Sexual Partners in the Last Three Years 
Respondents reported the number of sexual partners they had within 
the last three years. Students who reported zero to one were 36.5%, 
two to three 36.7%, four to five 10.6% and more than 5 sexual 
partners were 16.3%. 
 
4.4.1 Sexual Activity by Gender and Ethnicity. Of those sampled, 84.6% of the 
blacks reported being sexually active; while 70.8% whites were more likely to be in a 
monogamous relationship when compared to blacks.  As seen from Table 4.1 the highest 
percentage of blacks (41.0%) reported they had two to three sexual partners in the last 
three years.  Blacks reported having four or more sexual partners at a higher rate than 
Causasians/Whites. 
 Joy Kinnon, a reporter for Ebony Magazine, said “the bad news is that the number 
of black married couples is only half the number of married whites, and the situations is 
getting worse.”  Kinnion also explained that blacks marry at a lower rate and at an older 
age.  The Joint Center for Political and Economic Studies reports that by the age 30, 81% 
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of white women will be married, and only 52% of black women were married.  Research 
has proven that whites marry at a younger age than blacks.  This may be a reason why 
almost 50% of whites were more likely to be in a monogamous sexual relationship for the 
last three years. 
 
Table 4.1 Sexual Partners among Blacks and Whites 
Number of Partners Blacks Whites 
0-1 28.2% 47.6% 
2-3 41.0% 30.4% 
4-5 11.4% 8.9% 
More than 5 19.4% 13.1% 
Total 100% 100% 
 
4.4.2 Sexual Partners by Gender and Ethnicity. The highest percentages of 
individuals reporting having more than five sexual partners in the last three years were 
black males (37.5%).  On the other hand, the majority of the white males (43.5%) were in 
monogamous relationships with 0-1 sexual partners in the last three years (Table 5.1).  
Thirty percent of black and white males reported having only two to three sexual 
partners.  There was not a significant difference in sexual partners between white and 
black females. Both reported having zero to three sexual partners in the last three years at 
nearly 80%. 
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Table 5.1 Sexual Partners in the last three years 
Number of 
Partners 
 Black Males White Males  Black 
Females 
White 
Females 
0-1  20.5% 43.5%  33.5% 50.0% 
2-3  30.4% 30.6%  48.4% 30.2% 
4-5  11.6% 8.1%  11.2% 9.4% 
More than 5  37.5% 17.7%  6.8% 10.4% 
 
4.5 Knowledge of Human Papillomavirus 
 A total of 10 questions were used to determine the knowledge of college students.  
Responses from Table 6.1 indicate that only 36.7% of the college students correctly 
recognized that human papillomavirus is not a bacterial disease.  More than half of the 
students knew that human papillomavirus was the most common sexually transmitted 
infection in the United States (58%).  Survey participants also recognized the chance of 
contracting human papillomavirus correctly at 52.2%.  Of those students, 36.1% 
answered that he/she has a 50% chance of contracting human papillomavirus in his or her 
lifetime, which was the recognized percent from the Center for Disease Control.  The 
other 16.1% answered that there is a 75% chance of contracting human papillomavirus in 
one’s lifetime which correlated with the data from Merck & Company.  Respondents 
correctly answered that between 30-40 types of human papillomavirus infect the genital 
tract (63.7%).  
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Only 28.5% of survey participants correctly answered that males and females are 
infected equally with the HPV.  A majority of the respondents 64.5% believed that 
human papillomavirus infected females more than males.  Only 7.0% answered that 
males are usually infected with HPV more than females.  When asked, “Does a condom 
prevent transmission of human papillomavirus between partners,” 63.7% believed a 
condom would prevent the transmission of HPV.  Few answered correctly that a condom 
would not prevent transmission of HPV between partners.  Lastly, the vast majority of the 
respondents, 68.3%, recognized that it would be acceptable for a person under age 26 to 
receive the human papillomavirus vaccine before becoming sexually active or after 
becoming sexually active, and after being exposed to the human papillomavirus.  There 
was no significant difference in the amount of knowledge in the white and black 
populations.  
Nearly 60% of males and females believe that a condom will prevent the 
transmission of HPV; however, areas that are not covered by the condom are able to 
contract the virus during sexual intercourse.   Young adults also seem to be naïve to the 
fact that HPV is an “equal opportunity offender” it does not infect females more than 
males or vice versa according to the CDC.  Less than 40% of the population correctly 
responded that HPV is not a bacterial disease.   
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Table 6.1 Knowledge and Transmission on Human Papillomavirus 
Knowledge Test Questions Correct Response % Correct Response % 
M                  F 
HPV is a bacterial disease? 
(T/F) 
36.7 32.2% 39.6% 
HPV is the most common 
Sexually Transmitted 
Infection (STI) in the United 
States? (T/F) 
58 41.7% 42.2% 
What is the chance that one 
will contract HPV in his or 
her lifetime? 
52.2 46.7% 55.8% 
How many types of HPV 
infect the genital tract? 
63.7  60.3% 66.0% 
Which sex does HPV 
usually infect? 
28.5 34.1% 24.8% 
Does a condom prevent 
transmission of HPV 
between partners? (T/F) 
36.3 30.2% 40.3% 
When could a person under 
26 receive the HPV vaccine? 
68.3 66.8% 69.3% 
 
4.6 Knowledge of HPV Symptoms  
College students were asked to check all of the symptoms associated with human 
papillomavirus infections.  The symptoms were genital warts in males, genital warts in 
females, cervical cancer in females and throat and penis cancers in males.  More than 
50% of the students associated HPV with genital warts in females and cervical cancer in 
females (Table 7.1).  Fewer recognized that HPV was related to genital warts in males 
(44%).  Only a small number of respondents were aware that HPV was found in throat 
and penis cancers in males (18.3%); and anal and oral cancers in both sexes (23.9%).   
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Table 7.1 Knowledge on HPV Associations 
HPV is associated with…. Correct Response % Correct Response% 
        M                      F 
Genital warts in males 44 53.8 37.6 
Genital warts in females 52.6 55.8 50.5 
Cervical cancer in females 76.7 62.3 86.1 
Throat and penis cancers in 
males 
18.3 23.6 14.4 
Anal and oral cancers in 
males and females 
23.9 26.1 22.4 
 
 The study in Florida by Gerend and Magloire showed that survey participants 
knew that some types of HPV can lead to cervical cancer (92%) and genital warts (69%).  
The current study is showing that only 76.7% of college students knew that HPV was 
associated with cervical cancer.  More participants knew about symptoms in females than 
those in males.  The Greensboro Public Health Department also found that many people 
believe that HPV is a “female disease.”  There has to be a reason why there is a higher 
rate of knowledge on HPV being associated with cervical cancer and genital warts in 
Florida college students in comparison to that of North Carolina college students.  Further 
research needs to be done to evaluate educational measures pertaining to the human 
papillomavirus in Florida in comparison to that of North Carolina.      
   
4.6.1 Black and White Males (Knowledge of HPV Associations). White males 
were more aware that HPV is associated with genital warts in males and females, than 
were black makes and black and white females (Table 8.1).  White and black females 
were equally aware of HPV being associated with cervical cancer in females in 
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comparison to black and white males.  Black males were nearly 10% more aware of 
throat and penis cancer in males than any other group, and white females and black males 
had the highest knowledge of anal and oral cancers being related to HPV.  Overall, there 
seems to be a gender difference in students’ knowledge of the link between HPV and 
genital warts and different cancers in males and females.  
 
Table 8.1 Knowledge of HPV Associations between Black and White Males 
HPV is associated with….  Males  Correct 
Response  
 
  Black             White 
Females Correct Response 
 
Black                  White 
Genital warts in males 48.2% 62.9% 35.4% 41.5% 
Genital warts in females 50% 66.1% 51.6% 50.9% 
Cervical cancer in females 66.1% 59.7% 87.6% 84.9% 
Throat and penis cancers in 
males 
26.8% 16.1% 13.0% 15.1% 
Anal and oral cancers in males 
and females 
26.8% 16.1% 16.8% 27.4% 
 
4.7 Knowledge of HPV Infections 
A large number of respondents were not aware that most types of HPV infections 
are able to clear on their own and responded that they are unable to clear on their own 
and require medical attention (74.3%).  Only 18.9% of the respondents believed HPV 
infections sometimes clear on their own (Table 9.1).  Only 6.8% correctly answered, that 
most types of HPV usually clear on their own.   The responses from males and females 
showed no gender difference in the knowledge of HPV associations.  There was also no 
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significant difference between white and black males knowledge on HPV associations.  
The previous research study by Gerend and Magloire showed that less than 30% of 
respondents knew that most types of HPVs clear on their own.  Participants in this study 
were asked if the statement was true or false, while participants in the present study were 
asked in a multiple choice format.  We believe the multiple choice format is more 
reliable, because one does not have a 50% chance of guessing the correct answer.   
Most students in this study had a higher perceived misconception of HPV 
infections, because nearly 90% of HPVs clear on their own.  Only 10% of the population 
with HPV will develop symptoms and the strain of HPV is irrelevant.  The students 
probably associated HPV and related diseases with other sexually transmitted diseases 
and infections most of which require medical attention. Diseases such as Gonorrhea, 
Chlamydia, Syphillis and infection with human immunodeficiency virus always require 
medical attention.           
 
Table 9.1 Knowledge of HPV Infections 
Most types of HPV infections…. Response % Females 
Response % 
Males Response % 
Usually clear on their own  
(Correct Response) 
6.8 6.6 7.0 
Sometimes clear on their own 18.9 19.8 17.6 
Are unable to clear on their own 
and require medical attention 
74.3 73.6 75.4 
Total Response n=502 n=303 n=199 
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4.8 Knowledge of HPV Transmission 
Based on survey responses, 95.8% of the participants correctly answered, that 
HPV cannot be transmitted by holding hands (Table 10.1).  There were few respondents 
that recognized that HPV could be transmitted by French kissing (15.9%) and intimate 
skin to skin contact (32.9%).  Most respondents correctly identified that HPV can be 
transmitted by oral sex and sexual intercourse.  A comparison of male and females 
response rate to HPV transmission was similar. Further analysis determined that 
knowledge of HPV transmission was not different between black and white populations.   
 
Table 10.1 Distribution of Knowledge of HPV Transmission 
HPV can be transmitted 
through… 
Correct Response % Correct Response % 
  Males            Females 
Holding hands 95.8 94.5 96.7 
French kissing 15.9 20.1 13.2 
Intimate skin to skin contact 32.9 27.6 36.7 
Oral Sex 72.9 75.9 71.0 
Sexual Intercourse 95.8 91.5 98.7 
 
4.9 Knowledge Scale 
A knowledge scale was created 0-18 to look at the overall knowledge of college 
students (Figure 5.1).   Participants received one point for every correct response and zero 
points for every incorrect response.  The average knowledge score was 8.79.  Nearly 65% 
of the students scored a nine or less showing poor knowledge of HPV.  Close to 75% of 
the population scored a 14 or less representing a lack of adequate knowledge.  Only 1.2% 
of the population scored between 15 and 16.  No one received a perfect score out of 502 
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survey participants.   Overall, the HPV knowledge score of survey participants was very 
poor.  This differs from a similar study by Gerende and Magloire, which had evidence 
that 75% of the students had heard of the human papillomavirus, though there were 
misconceptions about the virus, general knowledge of HPV was high in Florida.  The 
current study showed no gender difference in the knowledge scale; even though females 
had a slightly higher mean and median (Table 11.1).  Further analysis was completed to 
determine if knowledge scale depended on factors such as university, classification, or 
ethnicity.  
 
 
Figure 5.1 Distribution of Knowledge Scores 
Students knowledge distribution on the human   
papillomavirus (n=502) was overall low and graph is 
skewed to the right. 
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Table 11.1 Knowledge Scale by Gender 
Gender Mean/ Std. 
Deviation 
N Median 
F 8.87/(s=2.47) 303 9.00 
M 8.67/(s=2.36) 199 8.00 
Total 8.79/(s=2.43) 502 9.00 
 
4.9.1 Knowledge Scores by University. A comparison of means examined the 
knowledge scores of the universities sampled (Table 12.1).  The highest scoring 
universities were UNCG (8.95) and NCAT (8.93).  The other two universities followed 
closely behind ECU (8.76) and NCCU (8.37).  Anova test showed there was no 
significant difference between the knowledge scores between universities (p = .280).  All 
of the knowledge score means and medians for universities were between eight and nine 
out of a possible 18 points.  The averages seen at each university were similar to that of 
the overall study population.  
 
Table 12.1 Distribution of Knowledge Scores by University 
College Mean/Std. 
Deviation 
N Median 
East Carolina University 8.76/(s=2.44) 122 8.00 
North Carolina Agricultural & 
Technical State University 
8.93/(s=2.38) 137 9.00 
North Carolina Central University 8.37/(s=2.59) 90 8.00 
University of North Carolina 
Greensboro 
8.95/(s=2.35) 153 9.00 
Total 8.79/(s=2.43) 502 9.00 
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4.9.2 Knowledge Scores by Classification. Graduate Students had a slightly 
higher knowledge scores than freshmen, sophomores, juniors and seniors (Table 13.1).  
However the graduate students (n=19) were a very small portion of our respondents and 
were not considered a representative sample.  Juniors had the lowest average knowledge 
score.  Sophomores had slightly more knowledge than freshman.  In spite of this, there is 
no significant difference between classification and knowledge scores.  The Anova test 
had an extremely high (p value = .379). 
 
Table 13.1 Knowledge Scores by Classification 
Classification Mean/Std. 
Deviation 
N Median 
Freshmen 8.82/(s=2.60) 152 8.00 
Sophomore 8.89/(s=2.87) 152 9.00 
Junior 8.45/(s=2.38) 98 8.00 
Senior 8.80/(s=2.53) 81 8.00 
Graduate Student 9.58/(s=2.87) 19 9.00 
Total 8.79/(s=2.43) 502 9.00 
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4.9.3 Knowledge Scores by Ethnicity. A comparison of knowledge scores by 
ethnicity showed that Asian American/Southeast Asian/Asian and Hispanics had the 
highest scores (Table 14.1).  However, they represented a very small portion of our 
sample (n=22, .08).  There was no significant difference of knowledge scores in African 
American/Black/African Descent ethnicities to that of Caucasian/ Whites.  Multi-racial 
survey participants had a average knowledge score over nine.  Native Americans scored 
the lowest on the knowledge scale.  They also had low representation in this study (n=3). 
 Gerend and Magloire 2008 also found no difference between knowledge scores 
across ethnicity.  However, it does differ from a study completed in Pittsburg by Akers et 
al in 2009.  Their study indicated that blacks were less aware of HPV than whites (Black 
89% vs. Whites 97%, p > 0.1).  Their survey was used to evaluate knowledge about HPV 
and the HPV vaccine, and the perception of the vaccine‘s efficiency and safety (Akers, et 
al., 2009). 
 
Table 14.1 Comparison of Means by Ethnicity * Knowledge Score 
Ethnicity Mean/ (Std. 
Deviation) 
N Median 
Asian American/ Southeast Asian/ 
Asian 
9.8/ (s=2.79) 11 9.00 
African American/ Black/African 
Descent 
8.66/(s=2.47) 273 8.00 
Caucasian/ White 8.90/(s=2.42) 168 9.00 
Hispanic/ Latino 9.27/(s=2.76) 11 8.00 
Multi-Racial 9.06/(s=1.90) 33 9.00 
Native American 7.33/(s=1.15) 3 8.00 
Other 8.00/(s=2.65) 3 9.00 
Total 8.79/(s=2.43) 502 9.00 
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4.10 Perception 
 Over 80% of our sample viewed their knowledge as average or poor (Figure 6.1).  
Their actual knowledge scores supported their perception.  It is interesting to note that the 
way students perceived their knowledge was correct, because 75% of the population 
scored poorly (knowledge score below 14) on HPV knowledge.  Less than five percent of 
the population perceived themselves to be well informed.  Nearly a third of the 
population perceived their knowledge as average. 
 
 
Figure 6.1 Distribution of How Students Perceived their Knowledge of HPV 
Based on survey responses 58% perceived their knowledge on HPV 
as poor, 37.8% average, and 4.2% as well informed.  
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4.10.1 Perception by Gender. A higher percentage of males perceived their 
knowledge of HPV as poor than females (Table 15.1).  More females thought their 
knowledge of HPV was average.  The actual mean knowledge score was higher in 
females than males.  The median for females was nine, and the median score for males 
was eight. Overall, the perceived knowledge of males and females was similar to that of 
actual knowledge (poor). 
  
Table 15.1 Distribution of Perceived Knowledge by Gender to Actual Knowledge 
 Poor Average Well Informed Actual Score 
Mean/ Median 
Females 53.1% 41.9% 5.0% 8.87/9.00 
Males 65.3% 31.7% 3.0% 8.67/8.00 
 
4.10.2 Perception in Blacks and Whites. Students’ perception of knowledge of 
HPV was different between blacks and whites.  Blacks had a higher perceived knowledge 
of HPV to that of their white counterparts.  Few survey participants reported that they 
were well informed on the human papillomavirus.  The actual mean knowledge score 
showed that both populations actually had poor knowledge of HPV.  Whites were slightly 
more knowledgeable about HPV than blacks.  However, there is no significant difference 
between the knowledge score of the two populations.  
Gender comparison by ethnicity in Table 16.1 showed that white females had the 
highest actual knowledge score.  However, all scores were very close together showing a 
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tenth of a point difference.   Median scores were highest in the all white sample and the 
sample of white females.  More white females perceived their knowledge as poor when 
compared to black females.  In general by gender and by ethnicity the overall knowledge 
scores were still relatively low.     
 
Table 16.1 Perception of Actual Knowledge by Gender and Ethnicity 
Population Poor Average Well 
Informed 
  True 
Knowledge 
Score 
(Mean/Max 
score) 
  
All Black 
Females 
Males 
52.0% 
47.8% 
58.0% 
42.1% 
44.7% 
38.4% 
5.9% 
7.5% 
3.6% 
 8.66/18 
8.69/18 
8.63/18 
  
All White 
Females 
Males 
64.9% 
60.4% 
72.6% 
32.7% 
37.7% 
24.2% 
2.4% 
1.9% 
3.2% 
 8.89/18 
9.00/18 
8.71/18 
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4.11 Attitude towards the HPV Vaccine Gardasil 
 Over 60% of the population wanted more information on the HPV vaccine 
Gardasil (Figure 7.1).  Nearly fifteen percent of the population did not know about the 
vaccine and were not interested in receiving more information on Gardasil.  Whereas, 
fourteen percent of respondents believed that they knew everything about Gardasil.  
There were gender differences between males and females (Figure 8.1).  More than 50% 
of the males did not know about Gardasil but would like more information.  Nearly half 
of the females reported they had heard of Gardasil but would like more information.  The 
findings of the current study were similar to that of Gerend & Magloire who found that 
64% of their study population was interested in HPV education. A cross tabulation was 
performed to see if there was a difference between white and black populations; and 
white and black males.  There was no significant difference to report. Since more than 
half of the population was interested in learning more about the HPV vaccine, methods of 
educating students about HPV and the vaccine should be implemented. 
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Figure 7.1 Distribution of Students’ Attitude towards Gardasil 
The percentage of survey respondents who did not know about the 
vaccine and were not interested in receiving more information on 
the vaccine were 14.9%, 31.3% did not know about the vaccine but 
would like more information, 39.6% had some information on the 
vaccine but would like more information, and 14.1% knew 
everything about the HPV vaccine Gardasil.  
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Figure 8.1 Attitude towards Gardasil Vaccinations by Gender 
The distribution of attitudes on Gardasil Vaccinations by Gender   
showed that 51.26% of males did not know about the vaccine but 
would like more information and 51.82% of females had some 
information on the vaccine but would like more information. 
 
4.12 The HPV Vaccine Gardasil 
The response to vaccinations was evenly divided with 31.87% of respondents 
having been vaccinated, 34.26% having not been vaccinated but would like to be, and 
33.86 % having not been vaccinated and do not want to be vaccinated (Figure 9.1).  
Further analysis was done to see if gender, university and ethnicity played a role in 
Gardasil vaccination rates. 
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Figure 9.1 Distribution of Gardasil Vaccination 
The percentage of students who did not want to be    
vaccinated 33.86%, those who would like to be vaccinated 
34.26%, and those that had been vaccinated 31.87%. 
 
4.12.1 Gardasil Vaccination by Gender. A cross tabulation was performed to 
determine the rate of Gardasil vaccination according to gender (Table 17.1).  More than 
half of the female participants had been vaccinated; whereas only 1% of male participants 
had been vaccinated.  The majority of the males had not been vaccinated and was not 
interested in receiving the Gardasil vaccine.  There is a statistically significant difference 
in the Gardasil vaccination rates based on gender (x2 = 149.633, p=.001).  Nearly 80% of 
females had been vaccinated or would be interested in receiving the Gardasil vaccine 
Figure 10.1.  Less than a quarter of females were not interested in receiving the Gardasil 
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vaccine.  On the other hand, more males (54.3%) were not interested in being vaccinated 
with Gardasil, but a large portion (44.7%) would consider being vaccinated.   
 
Figure 10.1 Gardasil Vaccinations by Gender 
The graph shows the percentage of students who did         
not want to be vaccinated, those that would like to be 
vaccinated, and those that have been vaccinated 
according to gender. 
 
Gardasil was originally approved (June 2006) for females and recently approved 
three years later for males (November 2009) by the Food and Drug Administration.  
More efforts have been made to target females, since the vaccine has been available for 
females longer. Even though Gardasil was approved for males, few campaigns or 
advertisements have been promoting the vaccination of males.  Numerous Gardasil 
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advertisements show the faces of women and young females in their campaigns.  This 
could be the reason that 50% of males are hesitant to receive the Gardasil vaccine.  
 
Table 17.1 Gardasil Vaccination based on Gender 
   
 Gender 
F M 
Gardasil No, and I do not want 
to be vaccinated 
 62 108 
 20.4% 54.3% 
No, but I would like to 
be vaccinated 
 83 89 
 27.4% 44.7% 
Yes, I have been 
vaccinated 
 158 2 
 52.1% 1.0% 
Total  303 199 
 100% 100% 
 
 
4.12.2 Gardasil Vaccination by University. There was a statistically significant 
difference between Gardasil Vaccinations between universities (x2 =28.39, p value = 
.001; Figure 11.1).  The University of North Carolina at Greensboro had the highest 
percentage of students who had been vaccinated and the highest number of students who 
did not want to be vaccinated. North Carolina Agricultural & Technical State University 
had the most students (n=65, 47.45%) who indicated that they would like to be 
vaccinated with the Gardasil vaccine. 
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Figure 11.1 Gardasil Vaccinations by University 
Graph shows Gardasil vaccinations by university NCAT  
22.63%, NCCU 35.6%, ECU 31.5%, and UNCG 38.56. 
 
Further analysis was conducted that observed Gardasil vaccination rates by 
gender at each university (Table 18.1).  More than half of the females at NCCU and 
UNCG had been vaccinated with the Gardasil vaccine.  Less than fifty percent of the 
females at ECU and NCAT had been vaccinated.  Almost 80% of females in all schools 
have or would like to be vaccinated and almost 20% have no interest in receiving the 
vaccination.  Eighty percent of males from UNCG and 70% of males from ECU were not 
vaccinated and expressed no interest in being vaccinated.  Over, 60% of males that 
attended NCAT and NCCU showed interest in receiving the Gardasil vaccine.  
Males that attend the historically black colleges (NCAT and NCCU) were more 
likely to have interest in being vaccinated with Gardasil.  Males that attended universities 
which were historically white (UNCG 81.9% and ECU 68.9%) had almost no interest in 
vaccination.  This means that the approach for increasing vaccination rates in males may 
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need to be different according to ethnicity.  In females, it is interesting that half of the 
females from NCCU and UNCG had been vaccinated.  Considering that NCCU is 
historically black and UNCG is historically white.  Females that attended NCAT and 
ECU had less than 50% vaccination rates.  There may be no major difference in 
vaccination rates between women according to ethnicity because Merk Pharmaceutical 
Company has spent millions of dollars to advertise Gardasil to a diversified group of 
women between the ages of 9-26. 
 
Table 18.1 Gardasil Vaccinations by University and Gender 
       ECU 
M               F 
NCA T 
M               F 
NCCU 
M              F 
UNCG 
M              F 
No, and not 
interested 
 
68.9% 
 
20.8% 
 
38% 
 
21.2% 
 
38.0% 
 
16.7% 
 
80.9% 
 
21.7% 
No, but 
interested in 
vaccine 
 
31.1% 
 
29.0% 
 
62.0% 
 
31.8% 
 
62.0% 
 
25.9% 
 
17.0% 
 
23.6% 
Yes, I have 
been 
vaccinated 
 
.0% 
 
49.4% 
 
.0% 
 
47.0% 
 
.0% 
 
57.4% 
 
2.1% 
 
54.7% 
Total 
(Frequency) 
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77 
 
71 
 
66 
 
71 
 
54 
 
47 
 
106 
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4.12.3 Gardasil Vaccination by Classification. Next, we looked at Gardasil 
vaccination across classification (Table 19.1).  Freshmen and sophomores had the highest 
percentage of respondents vaccinated with Gardasil.  The majority of junior respondents 
had not been vaccinated and did not want to be vaccinated with the vaccine.  All students 
showed interest in receiving the Gardasil vaccine.  The different classifications showed 
that students were divided by a third wanting the vaccine, a third not interested in the 
vaccine and those that had been vaccinated.  Chi-square test showed that there was no 
significant difference in Gardasil vaccination rates based on the classification of students. 
 
Table 19.1 Gardasil Vaccinations by Classification 
 Freshmen Sophomores Juniors Seniors Graduate 
Students 
No, and I 
do not 
want to be 
vaccinated 
29.6% 33.6% 37.7% 35.8% 42.1% 
No, but I 
would like 
to be 
vaccinated 
36.2% 29.6% 32.7% 39.5% 42.1% 
Yes, I 
have been 
vaccinated 
34.2% 36.8% 29.6% 24.7% 15.8% 
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4.12.4 Gardasil Vaccination and Community. Gardasil vaccinations were 
compared to community.  However, one hundred and fifty-five students failed to identify 
their hometown (Table 20.1).  Of the 350 students who did report their hometown, 
students from rural communities were more likely to report that they did not want to be 
vaccinated with Gardasil at a higher rate than students from urban communities.  Higher 
vaccination rates were seen in college students from urban communities.  However, more 
interest in Gardasil vaccination was seen in students from rural areas. 
There is some difference in the communities and Gardasil vaccinations (x2=8.715, 
p =.069).  However due to the fact that half of the population failed to report their 
hometown, it is difficult to draw definite conclusions.  Further research needs to be 
implemented to examine vaccination rates of students from rural and urban communities. 
This information will further aid in the development of educational materials on HPV and 
the Gardasil vaccine.  
 
Table 20.1 Gardasil Vaccinations by Community 
 Rural Urban Non-Reported 
No, and I do not 
want to be 
vaccinated 
37.0% 29.0% 38.1% 
No, but I would like 
to be vaccinated 
36.9% 38.3% 26.5% 
Yes, I have been 
vaccinated 
26.2% 32.7% 35.5% 
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4.12.5 Gardasil Vaccinations among Gender in Blacks and Whites. We also 
looked at two ethnicities, Caucasian/White and African American/Black/African Descent, 
to Gardasil vaccinations.  Analysis showed that differences in responses of the two 
ethnicities are statistically significant (x2 = 40.856, p = .001) (Table 21.1).  Black males 
(59.8%) would like to be vaccinated at a higher percentage of white males (19.4%).  
White males (80.3%) showed no interest in receiving the Gardasil vaccine in comparison 
to black males (38.4%).  More than half of the black (52.2%) and white (58.5%) females 
had been vaccinated with Gardasil.  Nearly 80% of the females had been vaccinated or 
would like to be vaccinated.   
Of the students who had received the Gardasil vaccine, whites were more likely to 
receive all three shots (80.3%); compared to blacks (67.8%).  However, 20.8% of blacks 
reported that it was not time for the next injection compared to whites (9.8%).  The 
reasons for not receiving all three shots of Gardasil differed between the two populations.  
Blacks reported that they had not received all three vaccinations because of monetary 
reasons or they just simply forgot to go back for other injections.  Whites reported that 
they had not received all three injections because of bad reactions and that they just 
decided not to finish the series of vaccinations.  The two populations had other reasons 
that were similar for not receiving all of the injections, such as time conflicts, phobia of 
needles, and being away from home at the time for the next injection.   
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Table 21.1 Gardasil Vaccination based on Ethnicity and Gender 
 African American/ 
Black/African 
Descent 
N=273 
M          F 
Caucasian/ 
White 
N=168 
 
M            F 
Gardasil No, and I do not want to be 
vaccinated 
38.4% 17.4% 80.6% 20.7% 
No, but I would like to be 
vaccinated 
59.8
% 
30.4% 19.4% 20.8 
 
Yes, I have been vaccinated 1.8% 52.2% 0% 58.5% 
Total n=112 n=161 n=62 n= 
106 
 
4.13 Perceived Barriers to Gardasil Vaccination 
Based on the responses from college students, most had not been vaccinated with 
Gardasil (66.3%), due to a lack of information on the vaccine and the disease.  Financial 
reasons, time conflicts, and personal reasons seemed to be common reasons students had 
not been vaccinated.  A moderate amount of college students reported that they had not 
been vaccinated, because they were not concerned with contracting HPV (28.7%).  These 
students explained that they were mostly in committed monogamous relationships.   
Other factors, such as religious reasons, not having a physician, and not feeling the need 
to be vaccinated were of lesser concern (Table 22.1).  There was not a major difference in 
the reasons for non-vaccination among female and male respondents.  More males 
responded that they did not have enough information on the vaccine and disease, also 
they were not concerned with contracting HPV in comparison to females.  Females 
reported that they have not been vaccinated due to personal reasons at a higher rate than 
males. 
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Overall, lack of information on the vaccine and disease seems to be the major 
reason that two thirds of the population had not been vaccinated with Gardasil.  If more 
efforts were made to educate people on the human papillomavirus and the Gardasil 
vaccine, maybe there would be higher vaccination rates and lower incidence of related 
diseases. 
 
Table 22.1 Reasons for not being vaccinated 
Reasons for not being 
Vaccinated 
% of Females 
Responses 
% of Males 
Responses 
Percentage of 
Population % 
Lack of information on 
the vaccine and disease 
58% 72.3% 66.3% 
Financial Reasons                                     18.2% 15.9% 16.9% 
Time Conflicts                                                      22.4% 15.9% 18.6% 
Religious Reasons                                                                          2.1% 6.2% 4.4% 
Personal Reasons   19.6% 8.7% 13.3% 
I am not concerned 
with contracting HPV 
17.5% 36.9% 28.7% 
I do not have a 
physician 
8.4% 5.6% 6.8% 
I do not think the 
vaccine is safe 
22.4% 12.3% 16.6% 
Other reasons 12.6% 9.2% 10.7% 
No, because it would 
benefit women only 
0% 5.7% 3.3% 
Total 145 197 342 
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CHAPTER 5 
Conclusions 
 
Most would think that college students would be lined up, as they did for the 
latest Apple gadget, the “iPad”, if they could acquire a vaccine to protect against the 
number one sexually transmitted infection (STI) in the United States of America, the 
human papillomavirus (HPV).   However, our research showed that college students in 
North Carolina are divided into thirds when it comes to the Gardasil vaccine.  A third of 
the population had been vaccinated, a third was interested in receiving the vaccine, and a 
third was not interested in receiving the Gardasil vaccine.  The most common perceived 
barrier to vaccination by both men and women was a lack of information on the vaccine 
and the associated diseases.  The Merck Pharmaceutical Company, public health 
agencies, universities, and communities must come together to educate young adults on 
the benefits of being vaccinated with Gardasil.        
 A comparison of knowledge scores to ethnicity showed that Asian 
American/Southeast Asian/Asian and Hispanics had the highest scores.  Unfortunately, 
we did not have significant numbers to represent the full population (n=22).  This group 
represented less than 5% of the total population.  A larger sample of Asian 
American/Southeast Asian/Asian and Hispanics would allow us to see if their higher 
knowledge scores are significant.  There may be a way these specific ethnic groups are 
receiving more information about HPV that could benefit other ethnic groups.   
The survey used in this study also should have asked females if they received a 
Papanicolaou Test (Pap Smear) in the last year, and if so, if it were normal or abnormal.  
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Abnormal cell changes on the cervix could be an indicator of cancerous cells on the 
cervix or cells that could become cancerous in later years if not removed.  It is important 
for women who are sexually active to receive a pap smear, yearly, because cervical 
cancer is the number two killer of women worldwide.  
Another limitation to this study is that 155 students failed to report their 
hometown.  More research needs to be done to see if students from rural or urban 
communities are more likely to be vaccinated.  This may lead to a decision that there 
needs to be a different approach in the development of educational materials for young 
adults who are from the city than those who are from the country.   Also, only 502 
college students were surveyed from North Carolina; this cannot fully represent all of the 
college students in North Carolina.  This study also failed to sample students that 
attended private colleges. 
This study should have asked participants, if they were currently single, in a 
monogamous relationship/married, or dating numerous partners.  The data is showing 
that white males are in a monogamous relationship at a higher rate than black males.  By 
asking the study participants what type of relationship they are in currently would have 
provided more insight into the trending data. 
 Future surveys should sample a diverse group of ethnicities, religions, and 
geographic locations as researchers continue to assess the knowledge, awareness and 
perception of HPV in North Carolina, the United States, and the world.  More public 
health initiatives need to be implemented to educate men and women on the possible 
benefits of the HPV vaccine Gardasil.    
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Physicians should encourage students to contact the student health center at their 
university for follow up injections; so that being away from home is not a reason for 
students not receiving all three shots of Gardasil.  The UNC system mandated that all 
North Carolina college students be insured.  If they were not on their parents or family 
guardian’s insurance, they had the option of school insurance.  There should not be any 
females enrolled in college who are unable to receive Gardasil vaccinations due to 
monetary reasons.  The student health insurance policies need to explain to students so 
that students are aware that a certain amount of money is allotted to students’ general 
“Well Being.”  To assure that well being, students should be informed that they can 
receive the vaccination for close to no cost.      
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APPENDIX A. SURVEY INSTRUMENT 
 
Human Papillomavirus (HPV) Knowledge and Awareness 
Among North Carolina College Students  
 
This study will explore the knowledge and awareness of North Carolina college 
students about the human papillomavirus (HPV). The study is being conducted by a 
Master’s Candidate in the Department of Biology at North Carolina Agricultural & 
Technical State University.  Participation in this survey is completely voluntary. The 
identity of survey participants will be kept confidential and anonymous. The 
responses collected will be used solely for research purposes. 
Directions
  
:  Please select the best single response to each question below, except where 
asked for multiple responses.  Please do not write your name anywhere on this form, so 
that your information will remain anonymous. 
1. What is your sex?  Male       Female 
 
2. What is your ethnicity?  
□ African American/ Black 
□ Asian American 
□ Caucasian/ White 
□ Hispanic/Latino 
□ Native American 
□ Other Please Specify 
 
3. What is your age?  
□ 18-22 
□ 23-26 
□ Older than 26 
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4. What is your classification? 
□ Freshman 
□ Sophomore 
□ Junior 
□ Senior 
□ Graduate Student 
 
5. What do you consider to be your “home” (before coming to college)?  (Please 
print)  
City: __________________ State: ________________   
  
 
6. What is your major? 
□ Biology/ Chemistry 
□ Economics/ Business 
□ Education 
□ Engineering 
□ Humanities/ Foreign Language 
□ Mathematics/ Physics 
□ Civics/ Social Sciences 
□ Communication 
□ Music/Theatre/Art 
□ Nursing 
□ Other Please Specify 
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7. What are your sources for receiving information regarding sexually transmitted 
diseases (STD’s) or infections (STI’s)? (Check all that apply) 
□ Physician or Student Health Center  
□ Television 
□ Internet 
□ Health Classes 
□ Magazines,  Books or Newspapers 
□ Word of Mouth Please Circle (Parent/Guardian, Friends, Teacher, 
Mentor) 
 
8. When was your last annual physical or gynecological examination? 
□ 6 months ago 
□ A year ago 
□ More than a year ago 
□ Never  
 
9. Are you sexually active?  
□ Yes 
□ No 
 
10. How many sexual partners have you had in the last 3 years? 
□ 0-1 
□ 2-3 
□ 4-5 
□ More than 5 
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Please answer the following questions about your knowledge of HPV and the 
Gardasil HPV vaccine. 
 
11. HPV is a bacterial disease?  
□ True 
□ False 
 
12. HPV is the most common Sexually Transmitted Infection (STI) in the United 
States?  
□ True 
□ False 
 
13. HPV is associated with (Check all that apply) 
□ Genital warts in males 
□ Genital warts in females 
□ Cervical cancer in females 
□ Throat and penis cancers in males 
□ Anal and oral cancers in males and females 
 
14. Most types of HPV infections………… 
□ Usually clear on their own 
□ Sometimes clear on their own 
□ Are unable to clear on their own and require medical attention 
 
15. What is the chance that one will contract HPV in his or her lifetime? 
□ 25%   chance 
□ 50%   chance 
□ 75%   chance 
□ 100%  chance 
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16. How many types of HPV infect the genital tract? 
□ Only 1 
□ Between 30-40 
□ More than 100 
 
17.   Which sex does HPV usually infect? 
□ Males more than females 
□ Females more than males 
□ Both are infected equally 
 
18. A condom will prevent transmission of HPV between partners. 
□ True 
□ False 
 
19. HPV can be transmitted through (Check all that apply) 
□ Holding hands 
□ French Kissing 
□ Intimate skin to skin contact 
□ Oral sex 
□ Sexual intercourse 
 
20. When could a person under 26 receive the HPV vaccine? 
□ Before becoming sexually active 
□ After becoming sexually active 
□ After being exposed to the HPV virus 
□ All of the above 
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21. How do you rate your knowledge of the human papillomavirus? 
□ 1-2 Poor 
□ 3-4 Average 
□ 5-6 Well Informed 
 
22. Have you ever been diagnosed with HPV? 
□ Yes 
□ No 
 
23. The HPV Vaccine Gardasil has been approved to protect against genital warts and 
cervical cancer. What is your attitude toward the vaccine? 
□ Don’t know about the vaccine and not interested in receiving more 
information on the vaccine 
□ Don’t know about the vaccine but would like more information on the 
vaccine 
□ Have some information about the vaccine but would like more information 
□ I know everything about the HPV vaccine 
 
24. Did you know that the Gardasil vaccine has been approved for males? 
□ Yes 
□ No 
 
25. Have you been vaccinated with the HPV vaccine Gardasil? 
□ Yes (CONTINUE TO QUESTION 26)  
□ No, but I would like to be vaccinated (SKIP TO QUESTION 26) 
□ No, and I do not want to be vaccinated (SKIP TO QUESTION 26) 
 
 
 
74 
26. Have you received all three injections of the Gardasil vaccine? 
□ Yes 
□ No, because it is not time for the next injection 
□ No, because of another reason (explain) 
Stop here……. Thank you for your participation! 
 
27. If you answered NO to question 24, please check the reasons for not receiving the 
Gardasil vaccine. Check your top 3 Reasons. 
□ Lack of information on the vaccine and disease 
□ Financial reasons 
□ Time conflicts 
□ Religious reasons 
□ Personal reasons 
□ I am not concerned with contracting HPV 
□ I do not have a physician 
□ I do not think the vaccine is safe 
□ I do not feel I need the vaccine because  
□ No, because it would benefit women only 
………………………………………THE END….…………………………………….. 
Thank you for participating in this survey. The information gathered will be used in 
the development of educational materials to increase students’ awareness on the 
Human Papillomavirus the Gardasil vaccine and its link to various cancers. Some 
questions were obtained from the Guilford County Public Health Department. If 
you have any questions regarding this survey, please email Aliza Alston at 
atalsto1@ncat.edu or contact Dr. Doretha B. Foushee at foushee@ncat.edu or (336) 
285-2160.  
 
 
 
75 
APPENDIX B. INFORMED CONSENT 
 
     
INFORMED CONSENT TO PARTICIPATE IN A RESEARCH STUDY 
 
 
 
 
Study Title:  Human Papillomavirus (HPV) Knowledge and Awareness Among North Carolina 
College Students 
PI: Aliza Alston 
 
Dear Respondent, 
  
I am inviting you participate in a research project to study the Human Papillomavirus. Along with 
this letter is a short questionnaire that asks a variety of questions about Human Papillomavirus.  I 
am asking you to look over the questionnaire and, if you choose to do so, complete it and return it 
to me.  This should require about ten minutes of your time. You must be 18 years of age to 
participate in this study. 
 
The results of this project will be analyzed. Through your participation I hope to understand the 
knowledge of HPV on college campuses.   I hope that the results of the survey will be useful for 
use in designing materials to be used in educating college students on the Human Papillomavirus 
in the future. I hope to share my results, by publishing them in a scientific journal. 
 
I do not know of any risks to you if you decide to participate in this survey, and I guarantee that 
your responses will not be identified with you personally. I promise not to share any information 
that identifies you with anyone outside my research group which consists of my advisory 
committee.   If you do not feel comfortable handing in your survey to me, you may also mail it to 
the Biology Department at North Carolina Agricultural & Technical State University. 
 
I hope you will take the time to complete this questionnaire and return it. Your participation is 
voluntary and there is no penalty if you do not participate.  Regardless of whether you choose to 
participate, please let me know if you would like a summary of my findings. To receive a 
summary, email me at atalsto1@ncat.edu. 
 
If you have any questions or concerns about completing the questionnaire or about being in this 
study, you may contact me at atalsto1@ncat.edu. You may also contact my research advisor at 
foushee@ncat.edu.  This project has been approved by the Institutional Review Board (IRB) at 
North Carolina A&T State University. 
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If you have any questions about your rights as a research study participant, you may contact the 
chair of the IRB through the North Carolina A & T State University Compliance Office at (336) 
334-7995 or rescomp@ncat.edu. 
 
If you agree to participate, you may keep this form and complete the survey. 
If you wish, you may skip any question or stop at any time. 
 
Sincerely.    
 
 
 
Aliza Alston 
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ECU CONSENT FORM  
Title of Research Study
 
:   
Human Papillomavirus (HPV) Knowledge and Awareness Among North Carolina 
College Students 
 
Principal Investigator:             Aliza Alston 
Contact Faculty Member: Dr. Jason Bond, Department of Biology 
Institution: East Carolina University 
Address
 
: Howell Science Complex, Greenville, NC 27858 
You are invited to participate in a research project to study the Human Papillomavirus.  
My name is Aliza Alston, and I am a graduate student at North Carolina Agricultural & 
Technical State University (NCA&TSU) currently pursuing a Master’s degree in 
Biology. This study constitutes the research aspect of my Master’s thesis. I obtained my 
BS degree in Biology in 2009 from East Carolina University. Dr. Bond was my field 
zoology teacher.  
INTRODUCTION 
 
If you decide to participate, you will be asked to fill out a questionnaire assessing various 
aspects of demographic information, knowledge and awareness of HPV and its 
vaccinations. We expect that your participation today will take approximately 10 minutes 
to complete. I do intend to publish my results in a scientific journal. 
PLAN AND PROCEDURES 
 
This survey will be administered face to face to willing participants.  Students will be 
recruited to participate in this study by several methods. Areas of surveillance include 
dining halls, student unions, plots, and the surrounding areas outside of the libraries. 
Secondly, an email will be sent to professors with students from different majors (Health, 
Biology 100, Psychology, English, etc.) informing them of an important study being 
conducted by a NCA&TSU graduate student. The email would simply ask professors, “If 
I may come to their classrooms at their convenience.” Lastly, I plan to contact 
organizational leaders on campus. I plan to do this to see if it is possible to pass out my 
survey during a group function. 
METHODS 
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We anticipate that this study poses no potential risks.  However, in the event that you are 
uncomfortable answering any question, please feel free to leave the question(s) blank. 
POTENTIAL RISKS AND DISCOMFORTS 
 
Participation in the study will be used to design educational materials to educate college 
students on the Human Papillomavirus.  
POTENTIAL BENEFITS 
 
Participation in this survey is completely voluntary. The identity of survey participants 
will be kept confidential and the responses collected will be used solely for research 
purposes. Information obtained in this study, will be known only to the principal 
investigator, researcher, and my advisory team. The results of the study will be reported 
in summary format, and no personally identifying information will be included on the 
survey form or with the results of the study. Completed surveys will be kept in a safe 
place and destroyed in 2017.  
SUBJECT PRIVACY AND CONFIDENTIALITY OF RECORDS 
 
There will be no additional costs to you resulting from participation in this study. 
COSTS OF PARTICIPATION 
 
Participating in this study is voluntary. There is no penalty if you do not participate.  
Regardless of whether you choose to participate, please let me know if you would like a 
summary of my findings. To receive a summary, email me at atalsto1@ncat.edu. 
VOLUNTARY PARTICIPATION 
 
The investigator will be available to answer any questions concerning this research, now 
or in the future.  You may contact the investigator, Aliza Alston, by email at 
atalsto1@ncat.edu.  If you have questions about your rights as a research participant you 
may call the ECU Chair of the University and Medical Center Institutional Review Board 
at phone number 252-744-2914. 
PERSONS TO CONTACT WITH QUESTIONS 
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I have read all of the above information, and have received satisfactory explanations in 
areas I did not understand, if any.  (A copy of this signed and dated consent form will be 
provided to you if desired). 
CONSENT TO PARTICIPATE 
 
_______________________________________________________________ 
Participant’s Name (PRINT)  Signature  Date Time 
 
PRINCIPAL INVESTIGATOR:  I confirm that the participant has read the contents of 
this consent document, the participant has indicated all questions have been answered to 
his or her satisfaction, and the participant has signed the document. 
 
________________________________________________________________ 
Principal Investigator’s Name (PRINT) Signature  Date Time 
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APPENDIX C. INSTITUTIONAL REVIEW BOARD APPROVAL 
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Office of Research Compliance 
2718 Beverly Cooper Moore and Irene Mitchell Moore  
Humanities and Research Administration Building  
P. O. Box 26170, Greensboro, NC  27402-6170  
336.256.1482 Phone 336.256.1482 Fax  
 
 
 
October 25, 2010 
 
 
Aliza Alston 
104 Barnes Hall 
 
 
Dear Ms. Alston:  
  
The IRB for the Protection of Human Participants in Research at The University of North 
Carolina at Greensboro (UNCG) is willing to accept the approval of project entitled 
“Human Papillomavirus (HPV) Knowledge and Awareness Among North Carolina 
Students” by A& T University. Access to participants on this campus must be cleared 
through the appropriate department prior to you collecting data on the UNCG campus.  
  
If you have any questions, please contact me at ecallen@uncg.edu or (336) 256-1482.  
  
Sincerely,  
  
  
  
  
Eric Allen, Director  
Office of Research Compliance  
  
  
 
 
 
 
 
 
 
